首页> 外文OA文献 >Serosal Invasion Strongly Associated With Recurrence After Curative Hepatic Resection of Hepatocellular Carcinoma

【2h】

Serosal Invasion Strongly Associated With Recurrence After Curative Hepatic Resection of Hepatocellular Carcinoma

机译：血液侵袭与肝细胞癌治疗肝切除后的复发性强烈相关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Fuminori Sonohara; Shuji Nomoto; Yoshikuni Inokawa; Mitsuro Kanda; Suguru Yamada; Tsutomu Fujii; Hiroyuki Sugimoto; Yasuhiro Kodera;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Serosal Invasion Strongly Associated With Recurrence After Curative Hepatic Resection of Hepatocellular Carcinoma: A Retrospective Study of 214 Consecutive Cases [J] . Sonohara Fuminori, Nomoto Shuji, Inokawa Yoshikuni, Medicine. . 2015,第9期

机译：浆液浸润与肝细胞癌根治性肝切除术后复发密切相关：回顾性研究214例病例
2. Serosal Invasion Strongly Associated With Recurrence After Curative Hepatic Resection of Hepatocellular Carcinoma: A Retrospective Study of 214 Consecutive Cases [J] . Sonohara Fuminori, Nomoto Shuji, Inokawa Yoshikuni, Medicine. . 2015,第9期

机译：浆液浸润与肝细胞癌根治性肝切除术后复发密切相关：回顾性研究214例病例
3. Serosal Invasion Strongly Associated With Recurrence After Curative Hepatic Resection of Hepatocellular Carcinoma A Retrospective Study of 214 Consecutive Cases [J] . Sonohara Fuminori, Nomoto Shuji, Inokawa Yoshikuni, Medicine. . 2015,第9期

机译：浆液浸润与肝细胞癌根治性肝切除术后复发密切相关— 214例病例回顾性研究
4. Prevention of recurrence for hepatocellular carcinoma after curative surgery [C] . J. M. LLOVET Falk Workshop . 2003

机译：治疗手术后肝细胞癌复发的预防
5. Macrotrabecular Massive, a Novel Hepatocellular Carcinoma Histological Subtype: Analysis of Post- Resection and Transplant Recurrence [D] . Jeon, Yejoo. 2019

机译：Macrootrabular巨大，一种新型肝细胞癌组织学亚型：分析切除后和移植复发
6. Serosal Invasion Strongly Associated With Recurrence After Curative Hepatic Resection of Hepatocellular Carcinoma [O] . Fuminori Sonohara, Shuji Nomoto, Yoshikuni Inokawa, -1

机译：浆液浸润与肝细胞癌根治性肝切除术后复发密切相关
7. A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after curative hepatic resection or ablation: EMERALD-2 [O] . J. Knox, A. Cheng, S. Cleary, 2019

机译：在治疗肝切除或消融后，患有或没有Bevacizumab的乳腺癌患者患者患者肝细胞癌患者的辅助治疗的3阶段研究：祖母绿 - 2

Serosal Invasion Strongly Associated With Recurrence After Curative Hepatic Resection of Hepatocellular Carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅